Abstract
Objective: Indians are more likely to develop metabolic syndrome (MetS). The additive predictive value of MetS components for cardiovascular disease is still under debate. The current study aimed to study the risk factors associated with MetS in coronary artery disease (CAD) patients.
Methods: This retrospective study was conducted in the Department of Biochemistry in collaboration with the Department of Medicine, Noida International Institute of Medical Sciences, Gautam Buddha Nagar, Up on 100 patients already diagnosed with CAD, attending medicine OPD and IPD. Anthropometric measurements, and estimation of fasting blood glucose, high-density lipoprotein-cholesterol, and triglycerides were done. MetS prevalence was estimated as per the guidelines of NCEP ATP III.
Results: In our study, we observed a high incidence of MetS in patients with CAD. MetS was diagnosed, gender-wise distribution resulted in 62% in females and 48% in males. Risk factors for MetS in CAD patients were highly significant with increasing age, sedentary lifestyle, and diabetes. Waist circumference, fasting blood glucose levels, and triacylglycerol were found to have a significant *p<0.001 value with MetS in CAD patients.
Conclusions: The current study found a strong link between MetS and its risk factors in CAD patients. Thus, the assessment of MetS and its components might help identify people at a higher risk of advancing CAD in the future. Hence, effective MetS management may significantly reduce morbidity and mortality due to CAD.
Publisher
Innovare Academic Sciences Pvt Ltd
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology
Reference18 articles.
1. Montazerifar F, Bolouri A, Mozaffar MM, Karajibani M. The prevalence of metabolic syndrome in coronary artery disease patients. Cardiol Res 2016;7:202-8. doi: 10.14740/cr507w, PMID 28197293
2. Younis A, Younis A, Tzur B, Peled Y, Shlomo N, Goldenberg I, et al. Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease. Cardiovasc Diabetol 2016;15:149. doi: 10.1186/s12933-016-0466-6, PMID 27793156
3. Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F,Delavari A, et al. Appropriate definition of metabolic syndrome among Iranian adults: Report of the Iranian national committee of obesity. Arch Iran Med 2010;13:426-8. PMID 20804311
4. Mahalle N, Garg MK, Naik SS, Kulkarni MV. Association of metabolic syndrome with the severity of coronary artery disease. Indian J Endocrinol Metab 2014;18:708-14. doi: 10.4103/2230-8210.139238, PMID 25285291
5. Ravikiran M, Bhansali A, Ravikumar P, Bhansali S, Dutta P, Thakur JS, et al. Prevalence and risk factors of metabolic syndrome among Asian Indians: A community survey. Diabetes Res Clin Pract 2010;89:181-8. doi: 10.1016/j.diabres.2010.03.010, PMID 20381187